vs

Side-by-side financial comparison of Infobird Co., Ltd (IFBD) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

Infobird Co., Ltd is the larger business by last-quarter revenue ($3.4M vs $2.0M, roughly 1.7× Roivant Sciences Ltd.). Infobird Co., Ltd runs the higher net margin — -46.7% vs -13301.2%, a 13254.5% gap on every dollar of revenue. On growth, Infobird Co., Ltd posted the faster year-over-year revenue change (17118.0% vs -77.8%).

Infobird Co., Ltd. is a China-based technology firm specializing in AI-powered customer engagement and smart customer service solutions. It serves clients across e-commerce, finance, telecommunications, and internet service sectors, offering cloud-based SaaS tools, intelligent call center systems, and customized digital operation support to help enterprises boost service efficiency and customer satisfaction.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

IFBD vs ROIV — Head-to-Head

Bigger by revenue
IFBD
IFBD
1.7× larger
IFBD
$3.4M
$2.0M
ROIV
Growing faster (revenue YoY)
IFBD
IFBD
+17195.8% gap
IFBD
17118.0%
-77.8%
ROIV
Higher net margin
IFBD
IFBD
13254.5% more per $
IFBD
-46.7%
-13301.2%
ROIV

Income Statement — Q2 FY2025 vs Q3 FY2026

Metric
IFBD
IFBD
ROIV
ROIV
Revenue
$3.4M
$2.0M
Net Profit
$-1.6M
$-265.9M
Gross Margin
37.2%
Operating Margin
-31.8%
-16966.1%
Net Margin
-46.7%
-13301.2%
Revenue YoY
17118.0%
-77.8%
Net Profit YoY
-98.1%
-257.0%
EPS (diluted)
$-0.41
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IFBD
IFBD
ROIV
ROIV
Q4 25
$2.0M
Q3 25
$1.6M
Q2 25
$3.4M
$2.2M
Q1 25
$-39.6M
Q4 24
$9.0M
Q3 24
$4.5M
Q2 24
$8.0M
Q1 24
$28.9M
Net Profit
IFBD
IFBD
ROIV
ROIV
Q4 25
$-265.9M
Q3 25
$-113.5M
Q2 25
$-1.6M
$-223.4M
Q1 25
$-206.5M
Q4 24
$169.4M
Q3 24
$-230.2M
Q2 24
$95.3M
Q1 24
$-151.1M
Gross Margin
IFBD
IFBD
ROIV
ROIV
Q4 25
Q3 25
Q2 25
37.2%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
IFBD
IFBD
ROIV
ROIV
Q4 25
-16966.1%
Q3 25
-19492.9%
Q2 25
-31.8%
-13130.0%
Q1 25
674.8%
Q4 24
-3042.6%
Q3 24
-7636.0%
Q2 24
-1279.5%
Q1 24
-919.5%
Net Margin
IFBD
IFBD
ROIV
ROIV
Q4 25
-13301.2%
Q3 25
-7225.9%
Q2 25
-46.7%
-10292.9%
Q1 25
521.8%
Q4 24
1878.3%
Q3 24
-5143.8%
Q2 24
1192.7%
Q1 24
-522.3%
EPS (diluted)
IFBD
IFBD
ROIV
ROIV
Q4 25
$-0.38
Q3 25
$-0.17
Q2 25
$-0.41
$-0.33
Q1 25
$-0.28
Q4 24
$0.23
Q3 24
$-0.31
Q2 24
$0.12
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IFBD
IFBD
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$698.0K
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$66.7M
$4.3B
Total Assets
$72.4M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IFBD
IFBD
ROIV
ROIV
Q4 25
$4.5B
Q3 25
$4.4B
Q2 25
$698.0K
$4.5B
Q1 25
$4.9B
Q4 24
$5.1B
Q3 24
$5.4B
Q2 24
$5.7B
Q1 24
$6.5B
Total Debt
IFBD
IFBD
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
IFBD
IFBD
ROIV
ROIV
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$66.7M
$4.3B
Q1 25
$4.7B
Q4 24
$5.2B
Q3 24
$5.2B
Q2 24
$5.4B
Q1 24
$6.0B
Total Assets
IFBD
IFBD
ROIV
ROIV
Q4 25
$5.2B
Q3 25
$5.1B
Q2 25
$72.4M
$5.0B
Q1 25
$5.4B
Q4 24
$5.8B
Q3 24
$6.2B
Q2 24
$6.5B
Q1 24
$7.2B
Debt / Equity
IFBD
IFBD
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IFBD
IFBD
ROIV
ROIV
Operating Cash FlowLast quarter
$1.1M
$-196.5M
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IFBD
IFBD
ROIV
ROIV
Q4 25
$-196.5M
Q3 25
$-185.7M
Q2 25
$1.1M
$-204.4M
Q1 25
$-172.6M
Q4 24
$-207.3M
Q3 24
$-266.8M
Q2 24
$-192.8M
Q1 24
$-108.5M
Free Cash Flow
IFBD
IFBD
ROIV
ROIV
Q4 25
$-201.4M
Q3 25
$-193.5M
Q2 25
$-208.4M
Q1 25
$-173.4M
Q4 24
$-209.1M
Q3 24
$-267.8M
Q2 24
$-193.8M
Q1 24
$-108.8M
FCF Margin
IFBD
IFBD
ROIV
ROIV
Q4 25
-10076.0%
Q3 25
-12317.8%
Q2 25
-9604.5%
Q1 25
438.1%
Q4 24
-2318.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
IFBD
IFBD
ROIV
ROIV
Q4 25
246.9%
Q3 25
499.6%
Q2 25
185.9%
Q1 25
-2.0%
Q4 24
20.3%
Q3 24
22.3%
Q2 24
12.1%
Q1 24
1.2%
Cash Conversion
IFBD
IFBD
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons